Charles river launches helper plasmid to streamline adeno-associated viral vector manufacturing

Wilmington, mass.--(business wire)--charles river laboratories international, inc. (nyse: crl) today announced the launch of its off-the-shelf phelper offering, which is designed to secure supply and streamline adeno-associated virus (aav)-based gene therapy programs from early discovery through commercial manufacturing. it is available immediately in research grade (rg), high quality (hq), and good manufacturing practice (gmp)-grade.
CRL Ratings Summary
CRL Quant Ranking